Website

eHealth First (EHF)

ICO

Last updated: May 04, 2018

eHealth First is an IT-platform for personalized health and longevity management based on blockchain, artificial Intelligence, machine learning and natural language Ppocessing.

IMPORTANT: By investing in this business you agree to ourDisclaimer. All information including our rating, is provided merely for informational purposes. CryptoTotem does not provide investment advice.

Overview

Product type	Platform
Whitepaper	Open

Bounty

What is eHealth First

The eHealth First is an IT-platform to support decision-making in the field of health management, longevity, diagnostics, the prevention and treatment of common diseases for non-specialist users, medical specialists and researchers based on blockchain technology, machine learning, natural language analysis, neural networks, big data, clinical epidemiology, evidence-based medicine and telemedicine.

Details

Pre-sales: May 10, 2018 - Jun 10, 2018
Pre-sale token supply: 2000000
Token supply: 85000000
Soft cap: 8,000

Legal

Blockchain Platform: Ethereum
Country limitations: China

Token info

Ticker: EHF
Type: Utility-token
Token standard: ERC-20
Accepted currencies: USD, BTC, ETH, EUR
Bonus program:
up to 1 000 000 - 50-70%

eHealth First Roadmap

March, 2018

Ethereum contract with ERC20 tokens.

March - April, 2018

Pre-ICO.

June - July, 2018

ICO.

August, 2018

Start of software development.

August - December, 2018

Start of Core developers, AI, ML and health professionals hiring.

December, 2018

Launch of EHF Token Exchange Trades.

May, 2019

Database prototype.

October, 2019

NLP test development, testing and implementation.

March - December, 2020

Development of universal format for recording aggregated data from biomedical research (clinical guidelines, EBM summaries, systematic
reviews, meta-analyses, clinical trials, observational studies).

September, 2020

Alpha version, applying NLP technology.

December, 2020

DCFS (ETCD, Swarm, IPFS) integration.

May, 2021

Major data sources of medical data NLP processed and analyzed in database.

March, 202

Marketplace prototype with EHF as main tokens.

September, 2021

Beta version with integration of major external data sources (available electronic medical records).

December, 2021

Beta version with Marketplace alpha release.

December, 2022

Start of development graphene (EOS) - based blockchain solution for complete integration of all services in one ecosystem.

February, 2023

Beta version with Marketplace beta release.

January, 2024

Launch of graphene-based blockchain for project and conversion of ERC20 tokens to graphene based tokens.

May, 2024

Version 1.0

September, 2024

Beta version of storage system for data in universal format for medical records and biomedical research aggregated data in graphene blockchain.

December, 2025

Version 2.0 and release version of storage system for data in universal format for medical records and biomedical research aggregated data in graphene blockchain.

Project team

Nickolay Kryuchkov

Chief Executive Officer

Arnold Mitnitski

Advisor in Mathematical Modeling of complex biomedical systems, Systems Biology of the aging process, Advanced Data Analysis.

Daria Khaltourina

Director, Public Health and Longevity Programs

Nick Guldemond

Advisor in Health Policy and Management, Clinical Epidemiology, Public Policy, eHealth, Clinical Neurology, Clinical Diagnostics, Clinical Studies, Aging and Longevity Studies

Aubrey De Grey

Advisor in Biomedical Gerontology, Aging and Longevity Studies, Biotechnology, Drug Assessment, Health Promotion

Denis Rysev

C.T.O., Blockchain and Health Records

Eray Ozkural

Director, Artificial Intelligence, Machine Learning and High-performance computing

Keith Comito

Senior Expert, Software Development

Edwina Rogers

Advisor in Health and Social Security Policy, Longevity and Aging Studies, Primary Care, Government Affairs and Lobbying, Strategic Planning and Entrepreneurship, Media and Public Relations, Legal and Regulatory Affairs

Sviatoslav Plavinski

Advisor in Clinical Epidemiology, Biostatistics, Advanced Data Analysis, Diagnostic Algorithms, Machine Learning in Medicine, Legal and Regulatory Affairs

João Pedro de Magalhães

Advisor in Aging and Longevity Studies, Genetics and Genomics, Therapy and Prevention of Ameliorate Age-Related diseases, Technological Trends, Transhumanism

Kalluri Subba Rao

Advisor in Clinical Genetics, Aging and Longevity Studies, Biochemistry, Neurobiology, Biotechnology

Victor Solntsev

Advisor in Financial Management, Business Models, Coaching, Project Management, Risk Assessment, Investment Strategy, Business Development

Paul Spiegel

Attorney at Law, Advisor in Legal and Regulatory Affairs (in the U.S.A.) for the biotechnology and IT industry, business structuring and startups, international business consulting, domestic and international intellectual property practice, publishing, li